BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 10228357)

  • 1. [Mycoses and their treatment in malignant hemopathies].
    Martino P; Girmenia C
    Recenti Prog Med; 1999 Mar; 90(3):160-8. PubMed ID: 10228357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of mycoses in patients with hematologic disease and cancer -- review of the literature.
    Ruhnke M; Maschmeyer G
    Eur J Med Res; 2002 May; 7(5):227-35. PubMed ID: 12069913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal infections in cancer patients: an escalating problem.
    Samonis G; Bafaloukos D
    In Vivo; 1992; 6(2):183-93. PubMed ID: 1525339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations in the approach to invasive fungal infection in patients with haematological malignancies.
    Bow EJ
    Br J Haematol; 2008 Jan; 140(2):133-52. PubMed ID: 18173752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive fungal infections in paediatric patients.
    Roilides E; Walsh TJ
    Clin Microbiol Infect; 2010 Sep; 16(9):1319-20. PubMed ID: 20678174
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent developments in the management of invasive fungal infections in patients with hematological malignancies.
    Karthaus M; Cornely OA
    Ann Hematol; 2005 Apr; 84(4):207-16. PubMed ID: 15614521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Invasive fungal infections in patients with hematological malignancies: a clinical approach].
    García-Ruiz JC; Pontón J
    Med Clin (Barc); 2000 Sep; 115(8):305-12. PubMed ID: 11093887
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pocket guide to invasive mycoses in onco-hematologic patients].
    Bermúdez A; Carreras E; De la Cámara R; Eraso E; Fortún J; García-Ruiz JC; Guarro J; Jarque I; Marcos de Lucas E; Mayayo E; Pastor FJ; Pemán J; Pontón J; Quindós G; Salavert M; Sanz MA; Zaragoza R
    Rev Iberoam Micol; 2009; Suppl():3-199. PubMed ID: 20143497
    [No Abstract]   [Full Text] [Related]  

  • 9. [Early diagnosis of invasive fungal infections in hematooncological patients by serological methods].
    Rácil Z; Kocmanová I; Wagnerová B; Lengerová M; Mayer J
    Vnitr Lek; 2007 Sep; 53(9):990-9. PubMed ID: 18019671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of intracranial fungal infections in patients with haematological malignancies.
    Mattiuzzi G; Giles FJ
    Br J Haematol; 2005 Nov; 131(3):287-300. PubMed ID: 16225648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of invasive fungal infections in neonates and children.
    Steinbach WJ
    Clin Microbiol Infect; 2010 Sep; 16(9):1321-7. PubMed ID: 20840541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Trends of invasive fungal infections in hematological malignancies and new antifungal agents].
    Mori T
    Rinsho Ketsueki; 2003 Jan; 44(1):8-13. PubMed ID: 12649831
    [No Abstract]   [Full Text] [Related]  

  • 13. Antifungal prophylaxis and treatment in patients with hematological malignancies.
    Hwang YY; Liang R
    Expert Rev Anti Infect Ther; 2010 Apr; 8(4):397-404. PubMed ID: 20377335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.
    Fung M; Kim J; Marty FM; Schwarzinger M; Koo S
    PLoS One; 2015; 10(11):e0140930. PubMed ID: 26554923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
    Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the management of fungal infections.
    Muñoz P; Valerio M; Vena A; Bouza E; Posteraro B; Lass-Flörl C; Sanguinetti M
    Mycoses; 2015 Jun; 58 Suppl 2():1. PubMed ID: 26033250
    [No Abstract]   [Full Text] [Related]  

  • 17. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices.
    Singh N
    Clin Infect Dis; 2001 Nov; 33(10):1692-6. PubMed ID: 11641825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in antifungal prevention and treatment.
    Groll AH; Tragiannidis A
    Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation.
    Michallet M; Ito JI
    J Clin Oncol; 2009 Jul; 27(20):3398-409. PubMed ID: 19487382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
    Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG
    J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.